Evolution of enhanced innate immune evasion by SARS-CoV-2
More about Open Access at the CrickAuthors list
Lucy G Thorne Mehdi Bouhaddou Ann-Kathrin Reuschl Lorena Zuliani-Alvarez Ben Polacco Adrian Pelin Jyoti Batra Matthew VX Whelan Myra Hosmillo Andrea Fossati Roberta Ragazzini Irwin Jungreis Manisha Ummadi Ajda Rojc Jane Turner Marie L Bischof Kirsten Obernier Hannes Braberg Margaret Soucheray Alicia Richards Kuei-Ho Chen Bhavya Harjai Danish Memon Joseph Hiatt Romel Rosales Briana L McGovern Aminu Jahun Jacqueline M Fabius Kris White Ian G Goodfellow Yasu Takeuchi Paola Bonfanti Kevan Shokat Natalia Jura Klim Verba Mahdad Noursadeghi Pedro Beltrao Manolis Kellis Danielle L Swaney Adolfo García-Sastre Clare Jolly Greg J Towers Nevan J Krogan Toggle all authors (43)
Abstract
Emergence of SARS-CoV-2 variants of concern (VOCs) suggests viral adaptation to enhance human-to-human transmission1,2. Although much effort has focused on characterisation of spike changes in VOCs, mutations outside spike likely contribute to adaptation. Here we used unbiased abundance proteomics, phosphoproteomics, RNAseq and viral replication assays to show that isolates of the Alpha (B.1.1.7) variant3 more effectively suppress innate immune responses in airway epithelial cells, compared to first wave isolates. We found that Alpha has dramatically increased subgenomic RNA and protein levels of N, Orf9b and Orf6, all known innate immune antagonists. Expression of Orf9b alone suppressed the innate immune response through interaction with TOM70, a mitochondrial protein required for RNA sensing adaptor MAVS activation. Moreover, the activity of Orf9b and its association with TOM70 was regulated by phosphorylation. We propose that more effective innate immune suppression, through enhanced expression of specific viral antagonist proteins, increases the likelihood of successful Alpha transmission, and may increase in vivo replication and duration of infection4. The importance of mutations outside Spike in adaptation of SARS-CoV-2 to humans is underscored by the observation that similar mutations exist in the Delta and Omicron N/Orf9b regulatory regions.
Journal details
Journal Nature
Volume 602
Issue number 7897
Pages 487-495
Available online
Publication date
Full text links
Publisher website (DOI) 10.1038/s41586-021-04352-y
Europe PubMed Central 34942634
Pubmed 34942634
Keywords
Related topics
Type of publication